Advertisement

Topics

Companies Related to "Comparison cytotoxicity membrane efflux pump inhibition HepG2 cells" [Most Relevant Company Matches] RSS

18:51 EDT 19th June 2019 | BioPortfolio

Here are the most relevant search results for "Comparison cytotoxicity membrane efflux pump inhibition HepG2 cells" found in our extensive corporate database of over 50,000 company records.

Showing "Comparison cytotoxicity membrane efflux pump inhibition HepG2 cells" Companies 1–25 of 1,000+

Relevant

Tandem Diabetes Care®, Inc.

Tandem Diabetes Care, Inc. (www.tandemdiabetes.com) is a medical device company with an innovative, user-centric and integrated approach to the design, development and commercialization of products for people with diabetes who use insulin. The Company manufactures and sells the t:slim® Insulin Pump, the slimmest and smallest durable insulin pump current...


Tandem Diabetes Care, Inc.

Tandem Diabetes Care, Inc. (www.tandemdiabetes.com) is a medical device company with an innovative, user-centric and integrated approach to the design, development and commercialization of products for people with diabetes who use insulin. The Company manufactures and sells the t:slim® Insulin Pump, the slimmest and smallest durable insulin pump current...

Koch Membrane Systems, Inc

For nearly four decades, Koch Membrane Systems, Inc. has led the way in developing innovative membrane technologies that serve a diverse range of industries and applications around the globe. KMS provides solutions to markets including industrial and municipal water and wastewater, food and life sciences and industrial processes helping thousands of industries reduce their water footprint, incre...


Ballard Power Systems

Ballard Power Systems is recognized as a world leader in the design, development and manufacture of zero-emission proton exchange membrane (PEM) fuel cells.Ballard’s mission is to make fuel cells a commercial reality. By concentrating on what Ballard does best, fuel cells, we are able to leverage our automotive fuel cell technology for less demanding non-automotive applications.

PChemLabs Vacuum and Optical Instruments

PChemLabs Specializes in Used Vacuum Equipment Sales and ServiceUsed Vacuum Equipment, Rebuilt Vacuum Pumps, Used Mechanical Pumps, Rebuilt Mechanical Pumps, Used Vaccum Pumps, Vacuum Pump Repair, Vacuum Pump Service, Vacuum Pump Rebuilding, Custom Vacuum Chambers, Vacuum Pump Oil, Vacuum Fittings, Rebuilt Vacuum Pumps, Rebuilt Turbomolecular Pumps, Used Turbo Pumps, Used Ion Pump Controllers, Ion...

Heat Biologics, Inc.

Heat Biologics (www.heatbio.com) (“Heat”) is a clinical-stage company immunotherapy company focused on developing its novel off-the-shelf “ImPACT” (Immune Pan-Antigen Cytotoxic Therapy) therapeutic vaccines to combat a wide range of cancers and other diseases. Heat’s ImPACT Therapy effectively reprograms tumor cells to “pump o...

Mpex Pharmaceuticals, Inc.

Mpex Pharmaceuticals is a clinical stage biopharmaceutical company whose mission is to develop important new therapies to combat the growing issue of antibiotic resistance. The company's internal development pipeline focuses on combining proprietary formulations, PK/PD strategies and novel potentiating agents with proven antibiotics to overcome or directly inhibit the molecular mechanisms in bacte...

Solvo Biotechnology

SOLVO Biotechnology - "The Transporter Company" is a privately held biopharmaceutical company established in 1999 by a group of pre-eminent scientists working in the areas of ABC transporter proteins and multi-drug resistance at leading Hungarian universities. The company holds patents relating to drug targets and modulators, gene therapy applications and functional aspects of pharmacogenetics. I...

Giner, Inc. and Giner Electrochemical Systems, LLC

Giner, Inc. and Giner Electrochemical Systems, LLC (GES) are world-class research and development firms, specializing in the development of proton- exchange membrane (PEM) based electrochemical technologies. GES applies membrane technology to fuel cells for power generation, high-pressure electrolyzers for regenerative power, hydrogen fuel production, and oxygen production for life support. Gine...

Circe Biomedical Incorporated

Circe Biomedical is committed to the development, production, and commercialization of novel bioartificial organs based on its proprietary mammalian cell and semi-permeable membrane technologies. These technologies enable the company to: Isolate, purify, and preserve primary mammalian cells Fabricate semipermeable, biocompatible membranes designed to regulate the passage of selected molecules D...

American Membrane Corporation

PES membrane products manufacturer. Roll stock and cartridges produced. PVDF, NT, and PP also offered. Disc membranes. First USA company manufacturing PES membrane in Asia.

BioDesign Inc.

The easy and economical way to dry and store all types of polyacrylamide and agarose gels. The unique pore configuration of BioDesignGelWrap allows the water in your gel to be readily evaporated directly through the BioDesignGelWrap membrane. BioDesignGelWrap bonds to both the gel surface and to itself. A dried gel is sealed between two layers of tough clear membrane

Esperance Pharmaceuticals, Inc.

Esperance Pharmaceuticals, Inc. is developing a new class of targeted anticancer drugs using its Cationic Lytic Peptide (CLYP(TM)) platform technology. These drug candidates, called targeted membrane-disrupting peptides (tMDPs) and antibody drug conjugates (ADCs), selectively kill cancer cells, including cells known to be resistant to chemotherapeutic drugs, without harming normal cells. Targeting...

Barnant

Barnant is known worldwide as a leading manufacturer of peristaltic pump technology; as the manufacturer of the highly regarded Masterflex® peristaltic pump line; and as a world-class innovator in the engineering, design, manufacturing and distribution of an extensive line of fluid handling and flow control products. This includes the other well-known brands

CBT Pharmaceuticals

CBT Pharmaceuticals is a life sciences company developing innovative oncology therapeutics targeting the growth and proliferation of cancer cells. The company is advancing a pipeline of four development-stage assets including CBT-101, an oral c-Met inhibitor targeting the epithelial-mesenchymal transition (EMT) pathway in cancers and CBT-501, a novel human...

BioDot, Inc

For the development and manufacture of Rapid Diagnostic test devices, Biosensors and BioChip Arrays. BioDot’s proprietary dispensing technology is based on the combination of a positive displacement reagent pump coupled to a drop forming actuator. The actuators include but are not limited to micro-solenoid, aerosol and piezoelectric. The positive displacement pump gives true quantitative dispens...

Synamem Corporation

Synamem is an early stage biotechnology company which has developed a unique and highly enabling platform for academic and industrial R&D. For the first time, naturally fluid and functional biological membranes have been integrated into a scaleable discovery system, where membrane components retain their natural biological signaling capabilities. It is becoming increasingly evident that spatial r...

OnKure

OnKure, Inc. is a biopharmaceutical company focused on the discovery and development of targeted small molecule drugs to improve the outcomes of patients afflicted with cancer. OnKure's drug candidates aim to treat patients by targeting malignant cells directly, by working in combination with other small molecule therapies and by priming the tumor microenv...

OnKure, Inc.

OnKure, Inc. is a biopharmaceutical company focused on the discovery and development of targeted small molecule drugs to improve the outcomes of patients afflicted with cancer. OnKure's drug candidates aim to treat patients by targeting malignant cells directly, by working in combination with other small molecule therapies and by priming the tumor microenv...

Amniox Medical, Inc.

AMNIOX™ Medical is the leader in Amnion regenerative tissue therapies. The human Amniotic Membrane (AM) products offered by AMNIOX Medical are preserved using the patented CRYOTEK™ Process. This unique process has been proven to be the only process that conserves the fetal scarless healing strategies innate to Amniotic Membrane. Our Amniotic Me...

IBIS Technologies BV

The IBIS iSPR is a novel imaging SPR instrument that allows the simultaneous monitoring of multiple binding interactions to the surface of one and the same sensor. This way, it can be used for real-time detection of the possible binding events to the many spots of a micoarray, for example. Thanks to it flexibility, the instrument can also be accomodated to be used as a, more conventionel, 1- and 2...

NantKwest Inc.

NantKwest (Nasdaq:NK) is a pioneering, next generation, clinical-stage immunotherapy company focused on harnessing the unique power of our immune system using natural killer (NK) cells to treat cancer, infectious diseases and inflammatory diseases. NK cells are the body’s first line of defense due to the innate ability of NK cells to rapidly identify ...

MedArray, Inc.

MedArray manufacturers dense (non-porous) silicone hollow fiber membrane devices for the exchange of gas in liquids and other gas streams. The membrane can operate at low pressures and flow rates, and at a wide range of temperatures. Applications include control of humidity, O2 and CO2 in controlled atmospheres; removal or concentration of VOCs from air or water; control of physiologic gases in ce...

V-LABS, INC

V-LABS, INC., was established in 1979 as an independent, private organization. They manufacture carbohydrates, polysaccharides, and glycosidic enzymes used in research in the food, biochemical, and pharmaceutical industries, as well as in universities and research institutions. They have utilized membrane separations in the isolation of natural polysaccharides and have developed molecular weight s...

Trimeris, Inc.

Trimeris, Inc. (Nasdaq: TRMS) is a biopharmaceutical company engaged in the commercialization of therapeutic agents for the treatment of viral disease. The core technology platform of fusion inhibition is based on blocking viral entry into host cells. FUZEON®, approved in the U.S., Canada and European Union, is the first in a new class of anti-HIV drugs ...


More From BioPortfolio on "Comparison cytotoxicity membrane efflux pump inhibition HepG2 cells"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks